SCHEMBL191452

SCHEMBL191452

Cn1ccnc1Sc1ccnc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 2/20 0.47
KMT2A Q03164 3/20 0.46
LMNA P02545 3/20 0.46
ALDH1A1 P00352 5/20 0.39
POLB P06746 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TP53 P04637 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
ALPL P05186 1/20 0.35
ALPG P10696 1/20 0.35
GLA P06280 1/20 0.35
ALOX15 P16050 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
USP2 O75604 1/20 0.34
HPGD P15428 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10395347 0.78 GCK (0.45) GCKKMT2ALMNAALDH1A1POLB
SCHEMBL11734656 0.74 GCK (0.52) GCKKMT2ALMNAALDH1A1NPC1
SCHEMBL3531433 0.74 GCK (0.52) GCKKMT2ALMNAALDH1A1POLB
SCHEMBL5654722 0.71 GCK (0.46) GCKKMT2ALMNAALDH1A1POLB
Hydrochloric Acid SCHEMBL10395339 0.71 LMNA (0.46) GCKKMT2ALMNAALDH1A1POLB
SCHEMBL10395383 0.70 POLB (0.46) GCKKMT2ALMNAALDH1A1POLB
SCHEMBL10395351 0.70 KMT2A (0.65) GCKKMT2ALMNAALDH1A1POLB
SCHEMBL190886 0.69 ALDH1A1 (0.53) KMT2ALMNAALDH1A1POLBHPGD
SCHEMBL1146435 0.69
Hydrochloric Acid SCHEMBL10396008 0.69 POLB (0.45) GCKKMT2ALMNAALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1986645-B1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC (US) 2012-01-04 EP disclosed
US-8022222-B2 Glucokinase activators ARRAY BIOPHARMA, INC. (US) 2011-09-20 US disclosed
US-20090247526-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2009-10-01 US disclosed
EP-1986645-A1 GLUCOKINASE ACTIVATORS Array Biopharma, Inc. (US) 2008-11-05 EP disclosed
WO-2007089512-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247526-A1 GLUCOKINASE ACTIVATORS GCKR, GCK, GALK1 GCK 2/4885KMT2A 2715/4885LMNA 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.